Massage Impact on Sleep in Pediatric Oncology
Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Mar 18, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of massage therapy on sleep for young patients with cancer, specifically those undergoing intensive treatments like chemotherapy or stem cell transplants. Researchers want to find out if massage can help improve sleep quality in these children and teenagers, who often face challenges with sleep during their treatment.
To participate in this study, young people aged 12 to 21 who are being treated for conditions like acute myeloid leukemia or are receiving stem cell transplants are eligible. They need to be staying at the hospital for at least 21 days. Participants will receive massage therapy during their treatment, and the study will look at how this affects their sleep. It's important to note that those with certain cognitive impairments or language barriers may not be able to participate. Overall, this trial aims to provide insight into how a simple therapy like massage can support the well-being of young cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Diagnosis of cancer, such as acute myeloid leukemia (AML) or relapsed acute lymphoblastic leukemia (rALL) OR admitted to receive autologous or allogeneic HSCT for any indication
- • 2. Expected to be an inpatient for at least 21 days
- • 3. Aged 12 to 21 years at enrollment.
- • 4. Inpatient at Children's National or Children's Hospital of Philadelphia (CHOP).
- Exclusion Criteria:
- • 1. Cognitive impairment sufficient to preclude completing questionnaires appropriately
- • 2. Insufficient knowledge of English or Spanish that would prohibit completing the study instruments
- • 3. Previous enrollment
About Children's Hospital Of Philadelphia
The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Washington, District Of Columbia, United States
Patients applied
Trial Officials
Tracey Jubelirer, MD
Principal Investigator
Children's Hospital of Philadelphia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported